We learned that high expression of IGF2BP3 is often related to a poorer OS in COAD samples of TCGA and the GSE 41258 dataset and IGF2BP3 is an independent prognostic biomarker for COAD patients. The gene discussed is IGF2BP3; the disease is colon adenocarcinoma.